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Abstract
Background: The relative contributions of the cytotoxic phenotype of P. aeruginosa expressing
type III secretory toxins and an immunocompromised condition lacking normal Toll-like receptor
4 (TLR4) signaling in the pathogenesis of acute lung injury and sepsis were evaluated in a mouse
model for Pseudomonas aeruginosa pneumonia. By using lipopolysaccharide-resistant C3H/HeJ mice
missing normal TLR4 signaling due to a mutation on the tlr4 gene, we evaluated how TLR4 signaling
modulates the pneumonia caused by cytotoxic P. aeruginosa expressing type III secretory toxins.
Methods: We infected C3H/HeJ or C3H/FeJ mice with three different doses of either a cytotoxic
P. aeruginosa strain (wild type PA103) or its non-cytotoxic isogenic mutant missing the type III
secretory toxins (PA103∆UT). Survival of the infected mice was evaluated, and the severity of acute
lung injury quantified by measuring alveolar epithelial permeability as an index of acute epithelial
injury and the water to dry weight ratios of lung homogenates as an index of lung edema.
Bacteriological analysis and cytokine assays were performed in the infected mice.
Results: Development of acute lung injury and sepsis was observed in all mouse strains when the
cytotoxic P. aeruginosa strain but not the non-cytotoxic strain was instilled in the airspaces of the
mice. Only C3H/HeJ mice had severe bacteremia and high mortality when a low dose of the
cytotoxic P. aeruginosa strain was instilled in their lungs.
Conclusion: The cytotoxic phenotype of P. aeruginosa is the critical factor causing acute lung injury
and sepsis in infected hosts. When the P. aeruginosa is a cytotoxic strain, the TLR4 signaling system
is essential to clear the batcteria to prevent lethal lung injury and bacteremia.
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Background
Pseudomonas aeruginosa (P. aeruginosa) frequently causes
acute pneumonia in immunocompromised individuals.
Patients who are mechanically ventilated are especially at
high risk for developing P. aeruginosa pneumonia [1,2]. In
addition, patients with P. aeruginosa pneumonia are more
likely to develop bacteremia, septic shock, and multiple
organ failure, and have a higher mortality than patients
with pneumonia due to other infectious agents [2,3].
A poorer prognosis of patients with P. aeruginosa pneumo-
nia is associated with specific virulence factors of P. aeru-
ginosa. We have reported that the ability of these bacteria
to cause acute epithelial injury involves the expression of
virulent toxins that are translocated directly into eukaryo-
tic cells via the type III secretion (TTS) system [4-9]. The
TTS system is utilized by most virulent pathogenic gram-
negative bacteria, including Yersinia, Salmonella, Shigella,
and E. coli [10,11]. The TTS system functions as a molecu-
lar syringe to deliver toxins directly into the cytosol of cells
and inhibit host immune responses [12-14]. In animal
models, cytotoxic P. aeruginosa strains expressing the TTS
toxins were able to consistently induce septic shock by
causing the dissemination of inflammatory mediators
from injured lungs into the circulation [15]. The adminis-
tration of anti-PcrV IgG blocked the TTS toxin transloca-
tion by P. aeruginosa and protected animals from lethal
pneumonia [16-18]. Recently, several studies also demon-
strated that patients infected with cytotoxic strains of P.
aeruginosa expressing the TTS toxins have a high risk of
mortality [19,20].
In infections with gram-negative bacteria including P. aer-
uginosa, endotoxin (lipopolysaccharide, LPS), a compo-
nent of bacterial outer membranes, has been reported to
be responsible for the pathogenesis of acute organ injury
and sepsis by provoking host inflammatory responses and
inducing systemic inflammatory syndromes [21]. The
acute immune response to LPS occurs mainly through
Toll-like receptor 4 (TLR4) [22,23]. In animal models of
P. aeruginosa pneumonia, release and accumulation of
inflammatory cytokines primarily occurs in the airspaces
of the infected lung. The inflammatory cytokines pro-
duced in the lung are able to disseminate into the circula-
tion across the lung epithelium damaged by the toxins
secreted from cytotoxic P. aeruginosa, leading to septic
shock [15]. The administration of interleukin-10, an anti-
inflammatory cytokine, suppresses the systemic inflam-
matory mediators leaking into the circulation from the
lungs and improves the survival of infected animals [15].
Therefore, two virulent components of P. aeruginosa, the
TTS system and LPS, appeared to be important in causing
sepsis associated with P. aeruginosa pneumonia.
In contrast, the inflammatory response to the airspace
instillation of LPS alone does not cause acute lung epithe-
lial injury [24]. In addition, neither lung injury nor septic
shock can be induced by the airspace instillation of non-
cytotoxic P. aeruginosa strains that are defective in the pro-
duction of TTS toxins [15]. Therefore, whether the
response to LPS through TLR4 becomes deleterious or
beneficial for infected hosts appears to be influenced by
the virulence of P. aeruginosa. Clinically, LPS-TLR4 signal-
ing has been a therapeutic target for preventing acute lung
injury and sepsis. However, the blockade of LPS-TLR4 sig-
naling may be harmful because recognition of bacterial
LPS through TLR4 and subsequent proinflammatory
responses in infected hosts must be important for innate
immunity against pathogens. In addition, the presence of
endogenous ligands for TLRs has been reported [25,26].
This implies that there are regulatory roles of TLR signal-
ing in inflammatory and immune responses against not
only infectious microbes but also endogenous harmful
stimuli.
In this investigation, the contributions of the cytotoxic
phenotype of P. aeruginosa and LPS-TLR4 signaling were
evaluated in a mouse model of P. aeruginosa pneumonia.
Using LPS-resistant C3H/HeJ mice missing normal TLR4
signaling due to a mutation on the tlr4 gene [27], we eval-
uated how TLR4 signaling modulated the development of
P. aeruginosa pneumonia induced by the airspace instilla-
tion of either a cytotoxic P. aeruginosa strain or its non-
cytotoxic isogenic mutant missing all TTS toxins. The out-
comes suggested that the role of TLR4 signaling in infected
hosts was important in clearance of the P. aeruginosa when
the bacteria causing pneumonia is a cytotoxic strain
expressing the type III secretory toxins.
Methods
Animals
Male C3H/FeJ and C3H/HeJ mice (8- to 12-week-old)
were purchased from Jackson Laboratories (Bar Harbor,
ME). Animals were housed in cages with filter tops in spe-
cific pathogen-free conditions. Sterile food and water were
provided ad lib. All experiments were done in compliance
with the Animal Care Committee Rules of the University
of California at San Francisco, and all protocols were
approved.
P. aeruginosa strains
P. aeruginosa parental PA103 strain and its isogenic
mutant PA103∆UT missing both ExoU and ExoT toxins
were generously provided by Dara W. Frank (Medical Col-
lege of Wisconsin, Milwaukee, WI) [15]. Bacteria from fro-
zen stocks were streaked onto trypticase soy agar plates
and grown in a deferrated dialysate of tryptic soy broth
supplemented with 10 mM nitrilotriacetic acid (Sigma
Chemical), 1% glycerol, and 100 mM monosodiumRespiratory Research 2004, 5 http://respiratory-research.com/content/5/1/1
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glutamate and grown at 33°C for 13 h in a shaking incu-
bator. Cultures were centrifuged at 8,500 × g for 5 min-
utes, and the bacterial pellet was washed twice and diluted
into the appropriate number of CFU/ml in lactated
Ringer's solution, determined by spectrophotometry. The
bacterial concentration was confirmed by plating out the
known dilutions of the samples on sheep blood agar
plates.
Intratracheal instillation
Mice were briefly anesthetized with inhaled sevoflurane
(Ultane, Abbot Laboratories, Abbot Park, Illinois, USA)
and placed supine, at an angle of approximately 30°. Fifty
microliters of bacterial solution were instilled slowly in
the left lobe of the lungs through a gavage needle (Modi-
fied animal feeding needle, 24 G, Popper & Sons, Inc.,
New Hyde Park, NY) inserted into the trachea via the
oropharynx. The proper insertion of the needle in the tra-
chea was confirmed by palpation of the tip of the blunt
needle through the skin and the observation of movement
of the solution inside the syringe with respiratory efforts
[28].
Quantification of acute lung injury
The severity of epithelial lung injury was quantified by
measuring the efflux of the 131I-labeled albumin (the alve-
olar protein tracer) across the alveolar epithelium into the
circulation, as previously described [28]. The alveolar
instillate was made up of 0.5 µCi of 131I-labeled human
serum albumin (Merck-Frost, Quebec, Canada) and 0.05
mg of anhydrous Evan's blue in 2 ml of lactated Ringer's
solution with 5% BSA. An appropriate quantity of the
specified P. aeruginosa was added to the 50 µl volume, if
the experiment was to include bacteria. The total radioac-
tivity (in counts/minute/g) in the instillate was measured
in a γ-ray counter (Auto-Gamma, model 5550, Packard,
Downers Grove, IL). Four hours after the instillation, mice
were deeply anesthetized with intraperitoneal sodium
pentobarbital. Blood was collected by a carotid arterial
puncture and median sternotomies were done to harvest
and measure the radioactivity of pleural fluids, lungs, tra-
cheas, oropharynxes and stomachs. The percentage of
radioactive albumin that left the lung and entered the cir-
culation was calculated by multiplying the counts per
gram measured in the terminal blood sample times the
blood volume of the animal (body weight × 0.07). The
lungs were homogenized in sterile containers with sterile
0.9% saline solution. Lung homogenates were placed in
pre-weighed aluminium pans and dried to constant
weight in an oven at 80°C for 3 days. The water to dry
weight ratios of lung homogenates were used as an index
of lung edema.
Bacteriological assay
Blood was plated onto sheep blood agar plates for quan-
titative assessment of CFU/ml. Lung homogenates were
sequentially diluted then plated onto sheep blood agar
plates. Colony forming units were calculated per gram of
tissue.
Bronchoalveolar lavage (BAL)
Mouse lungs were lavaged by instilling and withdrawing 1
ml of phosphate buffered saline (PBS). Supernatants of
centrifuged BAL fluids (BALF) were collected and proc-
essed for cytokine measurement.
Leukocyte counts in BALF
BALF samples were mixed with the solution including
0.01% crystal violet dye and 2.7% acetic acid for leukocyte
staining and erythrocyte hemolysis. The number of leuko-
cytes in BLAF was counted by a hemacytometer under a
microscope.
Determination of cytokine levels
Biological activity of TNFα in plasma and BALF was meas-
ured by analyzing the cytotoxicity of TNFα on the fibrosa-
rcoma cell line WEHI-13VAR, as reported previously
[15,29]. Cytokine ELISA was performed for IL-10, as pre-
viously described [28]. Sample concentrations were calcu-
lated by comparison with standard curves using
recombinant cytokine.
Statistical analysis
Mantel-Cox log rank test was used for survival analysis.
One-way analysis of variance (ANOVA) followed by the
Bonferroni multiple comparison test or the Dunn's Multi-
ple Comparisons test were used for comparisons among 3
groups. Student's t-test or Mann-Whitney test were used
for comparisons between 2 groups. The Kruskal-Wallis
non-parametric test with Dunn's test was used for the
comparisons of leukocyte counts in BALF. Significance
was accepted at p < 0.05.
Results
Survival study
To examine whether a lack of normal TLR4 signaling
affects the mortality induced by P. aeruginosa pneumonia,
we performed survival studies using LPS-resistant C3H/
HeJ mice. LPS-sensitive C3H/FeJ mice (the background
strain of C3H/HeJ) were used as control groups. Mice
were intratracheally infected with wild type P. aeruginosa
PA103 at doses of either 5 × 103 CFU (low dose), 6 × 104
CFU (medium dose), or 5 × 105 CFU (high dose), or with
an isogenic mutant PA103∆UT, which is missing the
expression of TTS toxins (ExoU and ExoT), at a dose of 5
× 105 CFU (high dose).Respiratory Research 2004, 5 http://respiratory-research.com/content/5/1/1
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After the instillation of a low dose (5 × 103 CFU) wild type
PA103, 30% of LPS-resistant C3H/HeJ mice died in 3
days, while all C3H/FeJ survived for a week (Fig. 1a).
However, statistically significant difference was not
detected between the two strains of mice. After the instil-
lation of a medium dose (6 × 104 CFU) of wild type
PA103, 65% of LPS-resistant C3H/HeJ mice died in 4
days, while all C3H/FeJ survived for a week (Fig. 1b).
There was statistically significant difference between C3H/
HeJ and C3H/FeJ mice. After the instillation of high dose
(5 × 105 CFU) wild type PA103, only 30% of C3H/FeJ and
only 15% C3H/HeJ mice, respectively, survived for more
than 3 days (Fig. 1c). The results suggest that, in the com-
parison between C3H/HeJ and C3H/FeJ mice, LPS-resist-
ant C3H/HeJ mice were more susceptible to wild type
PA103 at three different doses. The result implies that
defective TLR4 signaling was not beneficial for the survival
of infected mice with cytotoxic PA103.
Next, we examined whether the mortality of infected mice
depended on the phenotypes of the TTS toxins of P. aeru-
ginosa. An isogenic mutant PA103∆UT missing ExoU and
ExoT was intratracheally administered at a high dose (5 ×
105 CFU) to the airspaces of C3H/HeJ and C3H/FeJ mice.
Although instilled at a high dose, none of the mice died
for a week (Fig. 1d). Therefore, the mortality we observed
in the mice infected with a high dose of P. aeruginosa
PA103 was totally dependent upon the TTS virulence of P.
aeruginosa rather than the genotype of TLR4 in mice.
Acute lung injury
We quantified acute lung injury in the mice infected with
P. aeruginosa. Acute lung epithelial damage was quantified
by measuring the efflux of alveolar protein tracers from
the lungs into the bloodstream (Fig. 2a). Lung edema was
quantified by measuring the water to dry weight ratios of
the lung (Fig. 2b). The instillation of a high dose (5 × 105
CFU) of PA103 led to a significant increase of lung epithe-
lial injury (Fig. 2a) and severe increases of lung edema
(Fig. 2b) in both groups of mice. When the mice were
infected with a medium dose (6 × 104 CFU) of PA103,
both severe lung epithelial injury and lung edema
occurred in the both mouse strains (Fig. 2a). Although the
injury levels in C3H/HeJ were slightly higher, these were
not statistically significant. In contrast, the intratracheal
instillation of PA103∆UT even at a high dose (5 × 105
CFU) did not cause lung injury in either of the mice (Fig.
2a and 2b). This implies that, in our mouse model, the
bacterial dose and virulence of the bacteria, but not the
TLR4 phenotype of mice, determines the initial severity of
acute lung injury. Because more C3H/HeJ mice infected
with a medium dose (6 × 104 CFU) of PA103 died 3 days
after infection in the survival studies (Fig. 1a), we ana-
lyzed lung edema 3 days after a medium dose instillation
(6 × 104 CFU) of PA103 in the strains of mice. In contrast
Survival study. Figure 1
Survival study. An inoculum of either PA103 (5 × 105 CFU 
or 6 × 104 CFU) or PA103∆UT (5 × 105 CFU) was instilled 
into the lung of mice, then the survival was monitored for 7 
days. n = 10 / group. a. PA103 (5 × 105 CFU). b. PA103 (6 × 
104 CFU). c. PA103∆UT (5 × 105 CFU). *, p < 0.05 versus 
C3H/FeJ PA103 6 × 104 CFU group.
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to C3H/FeJ mice, C3H/HeJ mice showed a significantly
higher level of lung edema (Fig. 2c).
Lung bacterial clearance
We quantified the ability of the different strains of mice to
clear the bacteria from their infected lungs and the severity
of bacteremia during infection. Four hours after a high
dose instillation (5 × 105 CFU) of wild type PA103, both
strains of mice had similar quantities of bacteria in their
lungs (Fig. 3a). However, 4 h after the instillation of a
medium dose (6 × 104 CFU) of the wild type PA103, there
was a significantly larger quantity of bacteria in the lungs
of the C3H/HeJ mice. The quantity of bacteria in the lungs
of the C3H/HeJ mice was significantly increased after 3
days of infection (6 × 104 CFU) compared to the quantity
of bacteria in the C3H/FeJ mice (Fig. 3b). The lungs of
C3H/HeJ infected with high dose (5 × 105  CFU)
PA103∆UT also showed a significantly higher level of bac-
terial burden in their lungs in comparison to the lungs of
the C3H/FeJ mice (Fig. 3a) although all the mice survived
for a week after instillation of the same dose of PA103∆UT
in the survival study (Fig. 1c). This result implies that
C3H/HeJ mice could not clear the bacteria efficiently from
the infected lungs even 3 days after the infection (Fig. 3b).
Persistent lung infection observed in C3H/HeJ mice
explained higher edema (Fig. 2c) and mortality (Fig. 1a)
of the mice infected with a medium dose of PA103.
Bacteremia
We evaluated the severity of bacteremia in C3H/HeJ and
C3H/FeJ mice. Only a high dose instillation of PA103
caused detectable bacteremia 4 h after the infection in
either strain of mice (Fig. 3c). Among the two strains,
C3H/HeJ mice showed a significantly higher level of bac-
teremia 4 h after infection (Fig. 3c), although more than
70% of mice in the both strains eventually died within a
week after the instillation of bacteria (Fig. 1b). Neither the
instillation of a high dose of PA103∆UT nor the instilla-
tion of a medium dose of PA103 resulted in bacteremia 4
h after the infection (Fig. 3c). However, 3 days after the
instillation of the medium dose PA103, C3H/HeJ mice
showed a significantly greater level of bacteremia while
C3H/FeJ mice had either minimal bacteremia or none,
respectively (Fig. 3d). Therefore, the results imply that
decreased bacterial clearance probably lead to a delay in
the onset of bacteremia in C3H/HeJ mice.
Leukocytes in bronchoalveolar lavage fluids
We measured the number of leukocytes in BALFs which
were collected 16 h after infection from the mice infected
with either PA103 or PA103∆UT at a medium dose (Fig.
4). More leukocytes were found in the BALF from the mice
infected with PA103∆UT than in the BALF from the mice
infected with PA103. More leukocytes were found in the
BALF of C3H/FeJ mice than in the C3H/FeJ mice. The
Acute lung injury. Figure 2
Acute lung injury. Two parameters of lung damage were 
considered 4 h after the instillation made of the protein 
tracer 131I-labeled albumin and either PA103 (5 × 105 CFU or 
6 × 104 CFU), or PA103∆UT (5 × 105 CFU), or no bacteria. a. 
Efflux of protein tracer into the bloodstream was calculated 
as a percentage of the total instilled amount to quantify lung 
epithelial injury. b. Water to dry weight ratios of lungs as 
index of lung edema. Data are means ± SE. n = 3 in control 
groups (no bacteria), and n = 5 in other groups. *, p < 0.05 
versus C3H/FeJ, †, p < 0.05 versus no bacteria.
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Bacteriology. Figure 3
Bacteriology. Mice were infected with PA103 (5 × 105 CFU or 6 × 104 CFU) or PA103∆UT (5 × 105 CFU). The number of 
viable bacteria remaining in the infected lungs and blood was counted 4 h and 2 days after the instillation. Lung homogenates 
were sequentially diluted with sterile water and placed on sheep blood agar plates for 24 h at 37°C. 100 µl of blood was plated 
on agar plates for 24 h at 37°C. a. Number of bacteria remaining in the lungs 4 h after infection. b. Number of bacteria remain-
ing in the lungs 2 days after PA103 6 × 104 CFU infection. c. Bacteremia (CFU/ml of blood) 4 h after infection. d. Bacteremia 
(CFU/ml of blood) 2 days after PA103 6 × 104 CFU infection. n = 5 in groups. Data are means ± SE. *, p < 0.05 versus C3H/FeJ.
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number of leukocytes in the BALF of C3H/FeJ mice
infected with PA103 was the lowest among the four
groups, and significantly lower than that of C3H/HeJ mice
infected with PA103∆UT. The results implied that C3H/
HeJ mice failed to recruit inflammatory cells efficiently
into the site of infection. In addition, when infection was
by virulent P. aeruginosa secreting TTS toxins, few leuko-
cytes were detected in BALF, implying that virulent P. aer-
uginosa  suppressed the proper inflammatory cell
recruitment or eliminated the recruited leukocytes by its
cytotoxicity.
TNFα and IL-10 levels
We measured concentrations of TNFα in BALF and in the
serum of infected animals. TNFα in BALF was almost
undetectable in C3H/HeJ mice 4 h after the instillation of
a high dose (5 × 105 CFU) of either wild type PA103 or of
PA103∆UT (Fig. 5a). Only in the C3H/FeJ mice there was
a significant difference in the TNFα in BALFs between
PA103 and PA103∆UT infections (Fig. 5a). Only C3H/FeJ
mice infected with a high dose of PA103 showed a signif-
icantly increased serum concentration of TNFα compared
to those in the other strains of mice infected with either
PA103 or PA103∆UT (Fig. 5b).
We also measured the serum concentration of the anti-
inflammatory cytokine IL-10 in the mice infected with a
high dose of PA103. The concentration of IL-10 4 h after
infection was higher in the C3H/HeJ mice, but the differ-
ence not statistically significant (Fig. 5c).
Discussion
This study was designed to determine the contributions of
the TTS system and LPS of P. aeruginosa in the pathogene-
sis of acute lung injury and bacteria-induced death. To
understand the role of TLR4 signaling in acute lung injury
and sepsis, we compared LPS-resistant C3H/HeJ mice,
which are refractory to the biological effects of LPS due to
the mutation of tlr4, to LPS-sensitive C3H/FeJ mice [27].
The two strains of mice received tracheal instillation of
either cytotoxic wild type P. aeruginosa PA103 or an iso-
genic strain PA103∆UT which is missing two critical TTS
toxins, ExoU and ExoT [15]. Three different doses of bac-
teria were tested in these mice. ExoU is a cytotoxin
inducing necrotic cell death by a mechanism associated
with its phospholipase activity [30]. ExoT is a 53-kDa
exoenzyme S possessing ADP-ribosyltransferase and small
GTPase-activating activities. ExoT blocks epithelial wound
healing [31]. The administration of large doses of
PA103∆UT did not cause any lung injury nor affect the
mortality of any strain of mice. Large doses of wild type
PA103 caused acute injury, bacteremia and death in the
both strains of mice. Although there appeared to be minor
differences in survival, there were no statistically signifi-
cant differences in the mortality rates between the strains
of mice infected with large doses of PA103. These results
suggest that the administration of large doses of bacteria
overwhelms host defense, even in mice with an intact LPS-
signaling pathway. Furthermore, although there was
abnormal clearance of the non-cytotoxic PA103∆UT in
the C3H/HeJ mice in comparison to the C3H/FeJ mice,
PA103∆UT did not cause lung injury. As no lung injury
occurred, PA103∆UT  did not disseminate, and all the
mice survived. These results demonstrate that organ injury
and mortality were not directly affected by P. aeruginosa
LPS or the TLR4 signaling of the infected mice.
In contrast, an intact TLR4 signaling pathway was clearly
essential for host protection from virulent PA103. More
C3H/HeJ mice died from a medium dose of PA103, and
some of C3H/HeJ mice still died even from the lowest
dose of PA103. When lung injury was measured after a
The number of leukocytes in bronchoalveolar lavage fluids. Figure 4
The number of leukocytes in bronchoalveolar lavage 
fluids. The numbers of leukocytes were measured in the 
bronchoalveolar lavage fluids collected from the mice 
infected with either PA103 5 × 104 CFU or PA103∆UT 5 × 
104 CFU. Closed and open circles mean each data. n = 5 in 
groups. Boxes are the first quartile with medians as central 
bars. *, p < 0.05 versus C3H/HeJ infected with PA103∆UT by 
the Kruskal-Wallis non-parametric test followed by the 
Dunn's test.
PA103 
C
3
H
/
H
e
J
C
3
H
/
F
e
J
PA103∆UT
C
3
H
/
H
e
J
C
3
H
/
F
e
J 10
4
10
5
10
6
10
7
10
8
L
e
u
k
o
c
y
t
e
s
 
i
n
 
B
A
L
F
*Respiratory Research 2004, 5 http://respiratory-research.com/content/5/1/1
Page 8 of 10
(page number not for citation purposes)
short interval, there was no statistical difference between
the acute lung injury produced by similar doses in either
the C3H/HeJ or C3H/FeJ mice. Therefore, a given dose of
cytotoxic bacteria produced a reproducible quantity of
lung injury, in a short interval, in both mice. However,
when the infections were allowed to persist for a longer
interval, the number of cytotoxic bacteria in the C3H/HeJ
multiplied to a greater extent and caused lung edema later.
The lack of bacterial clearance in the C3H/HeJ mice ulti-
mately led to relatively larger quantities of lung injury,
even when smaller doses of cytotoxic bacteria had been
administered. The bacteria were able to multiply to injuri-
ous levels, implying that, in the absence of normal TLR4
signaling, cytotoxic PA103 can avoid the host immune
clearance, disseminate into the bloodstream, and cause
the death of the infected animals. The low leukocyte
number and a lack of TNFα production in the infected air-
space in the C3H/HeJ mice could indicate the lack of a
normal inflammatory response that clears the bacteria
from the infected site in these mice missing normal TLR4
signaling. Therefore, immune responses modulated by
TLR4 signaling are important in the protecting hosts from
cytotoxic P. aeruginosa expressing TTS toxins.
LPS is a static component of gram-negative bacteria, while
the virulence associated with the TTS system relies on
active energy production by live bacteria; the TTS appara-
tus can be upregulated and TTS toxins need to be translo-
cated using bacterial energy [10,11,13]. Gram-negative
bacteria such as E. coli and P. aeruginosa possess LPS as a
component of their cell membranes, although there are
many variations in its pattern [32]. However, only patho-
genic strains of gram-negative bacteria possess the TTS sys-
tem [33,34]. In P. aeruginosa, only strains expressing the
TTS system can cause significant acute necrotic cell death
and tissue damage, while non-cytotoxic P. aeruginosa
missing TTS but still possessing LPS do not lead to tissue
damage [5,7]. Recently, there have been reports of endog-
enous stimulators of TLRs [25,26]. For TLR4, heparan sul-
fate, hyaluronan, HSP60 and HSP70, surfactant protein A,
and  β-defensin 2 have been all implicated as possible
endogenous ligands or stimulators [25,26,35]. These facts
suggest that TLRs play a role as surveillance receptors for
tissue injury and tissue remodelling as well as for infection
[35]. If TLR4 recognizes not only LPS but also degradation
products of endogenous macromolecules from necrotic
cells and microorganisms, and if this recognition pro-
vokes responses to limit tissue injury and induce remod-
elling, a lack of normal TLR4 signaling must be
disadvantageous during infections involving severe tissue
damage. The activation of this surveillance system must
be more important when cytotoxic P. aeruginosa infects
and causes tissue injury. Without having this surveillance
system, hosts may not be able to survive infection involv-
ing severe tissue damage. Members of the TLR and inter-
leukin-1 receptor (IL-1R) superfamily share an
intracytoplasmic Toll-IL-1 receptor (TIR) domain, which
mediates recruitment of the interleukin-1 receptor-associ-
Cytokines. Figure 5
Cytokines. TNFα and IL-10 levels were measured 10 h after P. aeruginosa infection (PA103 or PA103∆UT 5 × 105 CFU). a. 
TNFα levels in bronchoalveolar lavage fluids. b. TNFα levels in serum. c. IL-10 levels in serum 10 h after PA103 infection. Data 
are means ± SE. n = 8 – 10/group. *, p < 0.05 versus C3H/HeJ.
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ated kinase (IRAK) complex via TIR-containing adapter
molecules. Recently, 3 unrelated children with an
inherited IRAK-4 deficiency were reported. They were
prone to infections caused by pyogenic bacteria [36].
Their blood and fibroblast cells did not activate NF-κB or
mitogen-activated protein kinase (MAPK) and failed to
induce downstream cytokines in response to any of the
known ligands of TIR-bearing receptors. These findings
suggest that in humans the normal TLR signaling pathway
is crucial for protective immunity against specific virulent
bacteria and is redundant against most other
microorganisms. Our results suggest that, in P. aeruginosa
infections, the identification of the phenotype or geno-
type of P. aeruginosa could be useful clinically.
Conclusions
In P. aeruginosa infections, the cytotoxic phenotype of P.
aeruginosa is the most critical factor in causing acute lung
injury and sepsis in infected hosts. TLR4 signaling is
another important factor for the efficient clearance of bac-
teria in hosts infected with cytotoxic P. aeruginosa strains.
Authors' contributions
Karine Faure and Teiji Sawa carried out animal studies.
Temitayo Ajayi drafted and edited the manuscript. Junichi
Fujimoto, Nobuaki Shime and Kiyoshi Moriyama partici-
pated in the animal studies. Teiji Sawa and Jeanine P.
Wiener-Kronish conceived of the study, and participated
in its design and coordination. All authors read and
approved the final manuscript.
Abbreviations
BAL: Bronchoalveolar lavage, BALF: Bronchoalveolar lav-
age fluid, P. aeruginosa:Pseudomonas aeruginosa, TTS: type
III secretion, LPS: lipopolysaccharide, TLR: Toll-like
receptor.
Acknowledgements
This research was supported in part by the National Institutes of Health 
grants HL59239, AI44101 to Jeanine P. Wiener-Kronish; the National Insti-
tutes of Health grants HL067600 to Teiji Sawa; the American Lung Associ-
ation RG-004-N to Teiji Sawa;, a postdoctoral research funds from Vaincre 
La Mucoviscidose, France, and from Bourse Lavoisier, French Ministry of 
Foreign Affairs to Karine Faure.
References
1. Chastre J, Fagon JY: Ventilator-associated pneumonia.  Am J
Respir Crit Care Med 2002, 165:867-903.
2. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C: The
attributable morbidity and mortality of ventilator-associ-
ated pneumonia in the critically ill patient. The Canadian
Critical Trials Group.  Am J Respir Crit Care Med 1999,
159:1249-1256.
3. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre
A, Mercier JC, Offenstadt G, Regnier B: Incidence, risk factors,
and outcome of severe sepsis and septic shock in adults. A
multicenter prospective study in intensive care units. French
ICU Group for Severe Sepsis. JAMA 1995, 274:968-974.
4. Finck-Barbancon V, Goranson J, Zhu L, Sawa T, Wiener-Kronish JP,
Fleiszig SM, Wu C, Mende-Mueller L, Frank DW: ExoU expression
by Pseudomonas aeruginosa correlates with acute cytotoxic-
ity and epithelial injury. Mol Microbiol 1997, 25:547-557.
5. Fleiszig SM, Wiener-Kronish JP, Miyazaki H, Vallas V, Mostov KE,
Kanada D, Sawa T, Yen TS, Frank DW: Pseudomonas aeruginosa-
mediated cytotoxicity and invasion correlate with distinct
genotypes at the loci encoding exoenzyme S. Infect Immun
1997, 65:579-586.
6. Kudoh I, Wiener-Kronish JP, Hashimoto S, Pittet JF, Frank D: Exo-
product secretions of Pseudomonas aeruginosa strains influ-
ence severity of alveolar epithelial injury. Am J Physiol 1994,
267:L551-556.
7. Sawa T, Ohara M, Kurahashi K, Twining SS, Frank DW, Doroques DB,
Long T, Gropper MA, Wiener-Kronish JP: In vitro cellular toxicity
predicts Pseudomonas aeruginosa virulence in lung infections.
Infect Immun 1988, 66:3242-3249.
8. Wiener-Kronish JP, Frank DW, Sawa T: Mechanisms of lung epi-
thelial cell injury by acute by Pseudomonas aeruginosa. In
Molecular biology of acute lung injury Edited by: Clark RSB, Carcillo JA. Bos-
ton: Kluwer Academic Publishers; 2001:149-161. 
9. Wiener-Kronish JP, Sakuma T, Kudoh I, Pittet JF, Frank D, Dobbs L,
Vasil ML, Matthay MA: Alveolar epithelial injury and pleural
empyema in acute P. aeruginosa pneumonia in anesthetized
rabbits. J Appl Physiol 1993, 75:1661-1669.
10. Galan JE, Collmer A: Type III secretion machines: bacterial
devices for protein delivery into host cells.  Science 1999,
284:1322-1328.
11. Hueck CJ: Type III protein secretion systems in bacterial
pathogens of animals and plants. Microbiol Mol Biol Rev 1998,
62:379-433.
12. Barinaga M: A shared strategy for virulence.  Science 1996,
272:1261-1263.
13. Lee CA: Type III secretion systems: machines to deliver bac-
terial proteins into eukaryotic cells?  Trends Microbiol 1997,
5:148-156.
14. Mecsas J, Strauss EJ: Molecular mechanisms of bacterial viru-
lence: type III secretion and pathogenicity islands. Emerging
Infect Dis 1996, 2:271-284.
15. Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW,
Martin TR, Wiener-Kronish JP: Pathogenesis of septic shock in
Pseudomonas aeruginosa pneumonia.  J Clin Invest 1999,
104:743-750.
16. Sawa T, Yahr TL, Ohara M, Kurahashi K, Gropper MA, Wiener-Kro-
nish JP, Frank DW: Active and passive immunization with the
Pseudomonas V antigen protects against type III intoxication
and lung injury. Nat Med 1999, 5:392-398.
17. Shime N, Sawa T, Fujimoto J, Faure K, Allmond LR, Karaca T, Swan-
son BL, Spack EG, Wiener-Kronish JP: Therapeutic administra-
tion of anti-PcrV F(ab')2  in sepsis associated with
Pseudomonas aeruginosa. J Immunol 2001, 167:5880-5886.
18. Frank DW, Vallis A, Wiener-Kronish JP, Roy-Burman A, Spack EG,
Mullaney BP, Megdoud M, Marks JD, Fritz R, Sawa T: Generation
and characterization of a protective monoclonal antibody to
Pseudomonas aeruginosa PcrV. J Infect Dis 2002, 186:64-73.
19. Hauser AR, Cobb E, Bodi M, Mariscal D, Valles J, Engel JN, Rello J:
Type III protein secretion is associated with poor clinical
outcomes in patients with ventilator-associated pneumonia
caused by Pseudomonas aeruginosa.  Crit Care Med 2002,
30:521-528.
20. Roy-Burman A, Savel RH, Racine S, Swanson BL, Revadigar NS, Fuji-
moto J, Sawa T, Frank DW, Wiener-Kronish JP: Type III Protein
Secretion is Associated with Death in Lower Respiratory and
Systemic Pseudomonas aeruginosa infection. J Infect Dis 2001,
183:1767-1774.
21. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cun-
nion RE, Ognibene FP: Septic shock in humans. Advances in the
understanding of pathogenesis, cardiovascular dysfunction,
and therapy. Ann Intern Med 1990, 113:227-242.
22. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y,
Takeda K, Akira S: Cutting edge: Toll-like receptor 4 (TLR4)-
deficient mice are hyporesponsive to lipopolysaccharide: evi-
dence for TLR4 as the Lps gene product.  J Immunol 1999,
162:3749-752.
23. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P,
Malo D: Endotoxin-tolerant mice have mutations in Toll-like
receptor 4 (tlr4). J Exp Med 1999, 189:615-625.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Respiratory Research 2004, 5 http://respiratory-research.com/content/5/1/1
Page 10 of 10
(page number not for citation purposes)
24. Wiener-Kronish JP, Albertine KH, Matthay MA: Differential
responses of the endothelial and epithelial barriers of the
lung in sheep to Escherichia coli endotoxin. J Clin Invest 1991,
88:864-875.
25. Beg AA: Endogenous ligands of Toll-like receptors: implica-
tions for regulating inflammatory and immune responses.
Trends Immunol 2002, 23:509-512.
26. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Cher-
tov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, Kwak LW:
Toll-like receptor 4-dependent activation of dendritic cells
by β-defensin 2. Science 2002, 298:1025-1029.
27. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D,
Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P,
Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and
C57BL/10ScCr mice: mutations in tlr4  gene.  Science 1998,
282:2085-2088.
28. Sawa T, Corry DB, Gropper MA, Ohara M, Kurahashi K, Wiener-
Kronish JP: IL-10 improves lung injury and survival in Pseu-
domonas aeruginosa pneumonia. J Immunol 1997, 159:2858-2866.
29. Khabar KS, Siddiqui S, Armstrong JA: WEHI-13VAR: a stable and
sensitive variant of WEHI 164 clone 13 fibrosarcoma for
tumor necrosis factor bioassay. Immunol Lett 1995, 46:107-110.
30. Sato H, Frank DW, Hillard CJ, Feix JB, Pankhaniya RR, Moriyama K,
Finck-Barbancon V, Buchaklian A, Lei M, Long RM, Wiener-Kronish J,
Sawa T: The mechanism of action of the Pseudomonas aerugi-
nosa-encoded type III cytotoxin, ExoU.  EMBO J 2003,
22:2959-2969.
31. Geiser TK, Kazmierczak BI, Garrity-Ryan LK, Matthay MA, Engel JN:
Pseudomonas aeruginosa ExoT inhibits in vitro lung epithelial
wound repair. Cell Microbiol 2001, 3:223-236.
32. Rocchetta HL, Burrows LL, Lam JS: Genetics of O-antigen biosyn-
thesis in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 1999,
63:523-553.
33. Groisman EA, Ochman H: Pathogenicity islands: bacterial evo-
lution in quantum leaps. Cell 1996, 87:791-794.
34. Mel SF, Mekalanos JJ: Modulation of horizontal gene transfer in
pathogenic bacteria by in vivo signals. Cell 1996, 87:795-798.
35. Johnson GB, Brunn GJ, Tang AH, Platt JL: Evelutionalry clues to
the functions of the Toll-like family as surveillance receptors.
Trends Immunol 2003, 24:19-24.
36. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C,
Dupuis S, Feinberg J, Fieschi C, Elbim C, Hitchcock R, Lammas D, Dav-
ies G, Al-Ghonaium A, Al-Rayes H, Al-Jumaah S, Al-Hajjar S, Al-
Mohsen IZ, Frayha HH, Rucker R, Hawn TR, Aderem A, Tufenkeji H,
Haraguchi S, Day NK, Good RA, Gougerot-Pocidalo MA, Ozinsky A,
Casanova JL: Pyogenic bacterial infections in humans with
IRAK-4 deficiency. Science 2003, 299:2076-2079.